These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11827510)

  • 1. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 2. The Emergence of the Randomized, Controlled Trial.
    Bothwell LE; Podolsky SH
    N Engl J Med; 2016 Aug; 375(6):501-4. PubMed ID: 27509097
    [No Abstract]   [Full Text] [Related]  

  • 3. Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers.
    Chalmers I
    J R Soc Med; 2011 Sep; 104(9):383-6. PubMed ID: 21881090
    [No Abstract]   [Full Text] [Related]  

  • 4. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intentional ignorance: a history of blind assessment and placebo controls in medicine.
    Kaptchuk TJ
    Bull Hist Med; 1998; 72(3):389-433. PubMed ID: 9780448
    [No Abstract]   [Full Text] [Related]  

  • 7. Pragmatic trials, blinding, placebos, and the usefulness of the PRECIS-2 tool.
    Dal-Ré R
    Eur J Clin Pharmacol; 2021 Jul; 77(7):1071-1072. PubMed ID: 33442767
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating clinical research and bloodletting. (Seriously).
    Ilfeld BM; Mariano ER
    Reg Anesth Pain Med; 2010; 35(6):488-9. PubMed ID: 20975460
    [No Abstract]   [Full Text] [Related]  

  • 9. Questioning the methodological superiority of 'placebo' over 'active' controlled trials.
    Enkin MW
    Am J Bioeth; 2009 Sep; 9(9):66-7. PubMed ID: 19998202
    [No Abstract]   [Full Text] [Related]  

  • 10. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
    Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
    J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief history of the randomized controlled trial. From oranges and lemons to the gold standard.
    Meldrum ML
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):745-60, vii. PubMed ID: 10949771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.
    Hopton AK; Macpherson H
    Chin J Integr Med; 2011 Mar; 17(3):173-6. PubMed ID: 21359917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial design in rheumatoid arthritis: the past decade.
    Strand V; Sokolove J
    Arthritis Res Ther; 2009; 11(1):205. PubMed ID: 19232061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomisation in clinical trials.
    Beller EM; Gebski V; Keech AC
    Med J Aust; 2002 Nov; 177(10):565-7. PubMed ID: 12429008
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoption of the double dummy trial design to reduce observer bias in testing treatments.
    Marušić A; Ferenčić SF
    J R Soc Med; 2013 May; 106(5):196-8. PubMed ID: 23761529
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical aspects of randomization and blinding in randomized clinical trials.
    Bridgman S; Engebretsen L; Dainty K; Kirkley A; Maffulli N;
    Arthroscopy; 2003 Nov; 19(9):1000-6. PubMed ID: 14608321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing allocation concealment and blinding in randomised controlled trials: why bother?
    Schulz KF
    Evid Based Nurs; 2001 Jan; 4(1):4-6. PubMed ID: 11707879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinding in psychotherapy plus medication trials.
    Smith EG; Mathur A
    Am J Psychiatry; 2006 Jul; 163(7):1295. PubMed ID: 16816244
    [No Abstract]   [Full Text] [Related]  

  • 20. The quality of placebos used in randomized, controlled trials of lumbar and pelvic joint thrust manipulation-a systematic review.
    Puhl AA; Reinhart CJ; Doan JB; Vernon H
    Spine J; 2017 Mar; 17(3):445-456. PubMed ID: 27888138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.